PWM
EXAS

Parkworth Wealth Management’s Exact Sciences EXAS Stock Holding History

Parkworth Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$159 Buy
3
+1
+50% +$51 ﹤0.01% 1007
2025
Q1 		$87 Hold
2
– – ﹤0.01% 978
2024
Q4 		$112 Buy
+2
New +$124 ﹤0.01% 942

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Parkworth Wealth Management's EXAS Position: Q2 2025 in Review

Parkworth Wealth Management increased its Exact Sciences (EXAS) stake by 50% in Q2 2025, buying an estimated $51 and bringing the position to 3 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Parkworth Wealth Management first reported a position in EXAS in Q4 2024 and has held it in 3 quarters since. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Parkworth Wealth Management held 3 shares of Exact Sciences worth $159 as of Q2 2025.
  • Parkworth Wealth Management bought 1 Exact Sciences share in Q2 2025, an estimated $51.
  • Exact Sciences made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1007 holding.
  • Parkworth Wealth Management first reported a position in Exact Sciences in Q4 2024 and has held it in 3 quarters since.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.